Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.5813
Delayed Data
As of Jun 30
 -0.0005 / -0.09%
Today’s Change
0.55
Today|||52-Week Range
12.55
-81.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-66.8M22.6M-24.1M-6.1M
 
 
 
 
 
Depreciation12.0K29.0K12.0K13.0K
 
 
 
 
 
Total Other Cash Flow39.3M-42.6M3.6M-9.7M
 
 
 
 
 
Funds From Operations-27.5M-19.9M-20.5M-15.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-391.0K-8.1M1.6M1.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-27.1M-11.8M-22.1M-17.6M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.000.00275.0K
 
 
Capital Expenditures-882.0K-2.0M-2.7M-2.7M
 
 
 
 
 
Net Cash Flow Investing-882.0K-2.0M-2.7M-2.4M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.00287.0K1.3M0.00
 
 
 
Long Term Debt Reduction0.000.00-1.5M0.00
 
 
Net Proceeds Stock Sale43.1M639.0K41.7M9.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing62.0K-62.0K287.0K0.00
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing43.2M864.0K41.7M9.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash813.0K-882.0K-372.0K634.0K
 
 
 
 
 
 
Net Change In Cash15.2M-12.9M16.8M-10.8M